This one gets less play than the others – perhaps because of how courts sometimes use “communication” to get around it in non-prescription medical product cases (more on that to come), or sometimes because plaintiffs might use the same testimony to claim medical malpractice.But prescriber failure to read can be a powerful tool. [read post]

– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]